CytoSorbents Corporation
7 Deer Park Drive, Suite K
Monmouth Junction, New Jersey 08852
July 26, 2021
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Abby Adams
Re: | CytoSorbents Corporation |
Registration Statement on Form S-3 | |
Filed July 14, 2021 | |
File No. 333-257910 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, CytoSorbents Corporation (the “Company”) hereby requests acceleration of the effective date of the above referenced registration statement, as amended, so that such registration statement may become effective at 4:00 p.m. (Washington, D.C. time) on July 27, 2021, or as soon as practicable thereafter.
CYTOSORBENTS CORPORATION | ||
By: | /s/ Dr. Phillip P. Chan | |
Name: Dr. Phillip P. Chan | ||
Title: Chief Executive Officer |